Brainsway Ltd Adr stock is traded at $10.64, with a volume of 349,357. It is down -8.59% in the last 24 hours and down -9.60% over the past month. BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
Previous Close:
$11.64
Open:
$11.11
24h Volume:
349,357
Relative Volume:
3.56
Market Cap:
$428.29M
Revenue:
$56.60M
Net Income/Loss:
$8.82M
P/E Ratio:
47.58
EPS:
$0.2236
Net Cash Flow:
$12.12M
1W Performance:
-4.57%
1M Performance:
-9.60%
6M Performance:
-38.03%
1Y Performance:
+32.01%
1-Day Range:
$10.21$11.15
1-Week Range:
$10.21$12.25
52-Week Range:
$7.14$17.40
Brainsway Ltd Adr Stock (BWAY) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS